Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan · Delayed Price · Currency is TWD 138.50
0.00 (0.00%)
May 8, 2026, 1:30 PM CST
TPEX:6712 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 429.43 | 367.25 | 539.4 | 200.71 | 369.6 |
Depreciation & Amortization | 22.79 | 30.49 | 31.8 | 34.73 | 35.14 |
Other Amortization | 0.38 | 0.4 | 0.51 | 0.82 | 0.68 |
Loss (Gain) From Sale of Assets | - | 0.01 | - | 0 | -11.33 |
Loss (Gain) From Sale of Investments | -38.73 | 46.68 | -241.86 | 22.7 | -261.05 |
Loss (Gain) on Equity Investments | 9.25 | -52.09 | - | - | - |
Stock-Based Compensation | 62.4 | - | - | 0.79 | 2.14 |
Other Operating Activities | -31.4 | 69.34 | 63.59 | 32.04 | 26.66 |
Change in Accounts Receivable | -35.48 | -93.36 | -16.94 | -51.1 | -17.62 |
Change in Inventory | 4.33 | -10.95 | 19.22 | -31.53 | -21.28 |
Change in Accounts Payable | 18.28 | 1.8 | -5.74 | 14.08 | 9.96 |
Change in Unearned Revenue | 96.85 | 72.48 | 31.76 | 77.68 | 8.09 |
Change in Other Net Operating Assets | -1.76 | 8.29 | 0.01 | 18.27 | -5.29 |
Operating Cash Flow | 536.35 | 440.34 | 421.74 | 319.2 | 135.69 |
Operating Cash Flow Growth | 21.80% | 4.41% | 32.12% | 135.25% | - |
Capital Expenditures | -1.28 | -4.85 | -5.82 | -3.19 | -1.98 |
Sale of Property, Plant & Equipment | - | - | - | - | 28.1 |
Sale (Purchase) of Intangibles | -4.44 | -0.71 | -0.02 | -2.41 | -2.67 |
Investment in Securities | 183.02 | 22.76 | 64.31 | -279.19 | -316.21 |
Other Investing Activities | -43.03 | -40.67 | 3.12 | -2.52 | -4.06 |
Investing Cash Flow | 134.27 | -23.46 | 61.6 | -287.31 | -296.83 |
Short-Term Debt Issued | 250 | - | - | - | - |
Total Debt Issued | 250 | - | - | - | - |
Short-Term Debt Repaid | -250 | - | - | - | - |
Long-Term Debt Repaid | -10.71 | -11.59 | -11.92 | -11.11 | -10.02 |
Total Debt Repaid | -260.71 | -11.59 | -11.92 | -11.11 | -10.02 |
Net Debt Issued (Repaid) | -10.71 | -11.59 | -11.92 | -11.11 | -10.02 |
Issuance of Common Stock | 0.27 | 0.02 | 4.04 | 2.37 | 745.29 |
Repurchase of Common Stock | -349.42 | - | -356.35 | - | - |
Common Dividends Paid | -407.8 | -440.03 | -136.29 | -309.49 | - |
Other Financing Activities | 17.54 | -0.04 | 0.06 | -1.2 | -1.9 |
Financing Cash Flow | -750.13 | -451.64 | -500.47 | -319.43 | 733.36 |
Net Cash Flow | -79.51 | -34.77 | -17.13 | -287.53 | 572.22 |
Free Cash Flow | 535.07 | 435.49 | 415.92 | 316.02 | 133.7 |
Free Cash Flow Growth | 22.87% | 4.70% | 31.61% | 136.35% | - |
Free Cash Flow Margin | 52.59% | 46.63% | 54.84% | 50.36% | 30.47% |
Free Cash Flow Per Share | 6.08 | 4.91 | 4.61 | 3.46 | 1.47 |
Cash Interest Paid | 0.92 | 0.13 | 0.2 | 0.51 | 0.62 |
Cash Income Tax Paid | 118.93 | 68.57 | 19.66 | 31.17 | 0.04 |
Levered Free Cash Flow | 406.49 | 290.39 | 304.48 | 219.61 | 100.32 |
Unlevered Free Cash Flow | 407.07 | 290.47 | 304.6 | 219.92 | 100.7 |
Change in Working Capital | 82.22 | -21.74 | 28.3 | 27.4 | -26.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.